ThruppLDMillerRDElliottJWelchWD. Ceforanide dosage in the puerperium. Curr Ther Res1983; 34: 130–5.
3.
ParishLCWitkowskiJA. Ceforanide compared with cefazolin in skin and soft tissue infections. Cutis1984; 33: 313–9.
4.
GreenmanRLArceySMGuttermanDAZweigRM. Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus, endocarditis in parenteral drug abusers. Antimicrob Agents Chemother1984; 25: 16–9.
5.
CooperRHSavitchCBJosephWPMillsJ. Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis. Antimicrob Agents Chemother1981; 19: 256–9.
6.
BurchKHPohlodDSaravolatzLD. Ceforanide: In vitro and clinical evaluation. Antimicrob Agents Chemother1979; 16: 386–91.
7.
MusherDMFainsteinVYoungEJ. Treatment of cellulitis with ceforanide. Antimicrob Agents Chemother1980; 17: 254–7.
8.
LefrockJLHollowayWCarrBBSchellRF. In vitro and clinical evaluation of ceforanide. Am J Med Sci1984; 287: 21–5.
9.
ThirumoorthiMCBuckleyJAVincentCVKobosDDajaniAS. Efficacy and safety of ceforanide in the treatment of childhood infections. Pediatr Infect Dis1983; 2: 377–80.
